Abstract
<p style="text-align: justify;"><strong>Objectives:</strong> To determine the acceptability of Patient initiated side effects reporting system in their vernacular language. <strong>Methods:</strong> All the hundred participants were using simple non-probability sampling; participants were given red form and blue form 9 Central drug standard and control suspected adverse effects form for physicians and patients respectively), placed them comfortably and asked to compare and their answers were coded when there were ready to convey the answers. All the questions were closed ended with prior testing with Cronbach alpha value of 0.75 to find suitability, both sheets were give and time allotted for them to get acquaintainted and then questions were put forth. <strong>Results: </strong>Nearly 65 subjects were aware that even minor side effects should be reported in blue form by themselves while 35% percentage was not familiar with it. Another significant finding about 66% people was not familiar with their names or identity such as revealing it in the form. <strong>Conclusion:</strong> Having adverse drug reaction from and measures taken were laudable; however, suitability and feasibility in our Indian scenario should be improved. Population education may play a key role and appointing social pharmacist is also a key option to alleviate ground level disconnects. <p style="text-align: justify;"><strong>Key words: </strong>Patient initiated adverse drug reporting, Consumer side effects reporting from, Blue and red from.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.